Evolving management of relapsed CLL: UK CLL Forum analysis of ibrutinib at first relapse
There are an array of new strategies evolving to manage relapsed chronic lymphocytic leukemia (CLL). In this interview, George Follows, MA, BM, BCh, PhD, FRCP, FRCPath, from Cambridge University Hospi...
Author: VJHemOnc
Added: 05/04/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cambridge University | Cancer & Oncology | Chronic Leukemia | Chronic Lymphocytic Leukemia | Leukemia